pentobarbital raises toxicity of methoxyflurane by escalating metabolism. Contraindicated. Elevated metabolism of methoxyflurane to nephrotoxic compounds.
pentobarbital will lessen the level or outcome of dasatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
Sedatives used throughout medical procedures may perhaps affect Mind enhancement in a younger child or unborn toddler (when Utilized in the mother), resulting in Studying or conduct difficulties later on in everyday life. Very long surgical procedures or repeated techniques pose the best risks.
Slight (1)pentobarbital will reduce the extent or influence of paclitaxel protein certain by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Mysterious.
Contraindicated (1)pentobarbital will decrease the extent or impact of fostemsavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the level or result of imatinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unknown.
pentobarbital will lessen the level or impact of abemaciclib by affecting hepatic/intestinal enzyme click here CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration of abemaciclib with powerful CYP3A4 inducers lessens plasma concentration of abemaciclib and its metabolites.
pentobarbital will lessen the extent or outcome of pimozide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
pentobarbital will minimize the level or effect of clozapine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will reduce the level or result of nitrendipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unfamiliar.
A standardized focus for this drug has long been established by way of Standardize four Safety (S4S), a countrywide individual safety initiative to cut back medication glitches, Primarily through transitions of treatment.
Contraindicated (1)pentobarbital decreases amounts of panobinostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Potent CYP3A4 inducers can lessen panobinostat degrees by ~70% and bring about treatment failure.
Keep an eye on Carefully (1)pentobarbital will lower the extent or result of mifepristone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. CYP3A4 inducers haven't been studied, coadministration not recommended by manufacturer
fentanyl transdermal and pentobarbital both of those increase sedation. Avoid or Use Alternate Drug. Restrict use to people for whom alternative treatment possibilities are inadequate